Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Peptide Vials (BPC-157 + TB-500 20 mg Blend): 4 weeks (28 doses at ~0.671.0 mg/day): 2 vials 6 weeks (42 doses): 3 vials 8 weeks (56 doses): 34 vials Insulin Syringes (U-100): Per week: 7 syringes (1/day) 4 weeks: 28 syringes 6 weeks: 42 syringes 8 weeks: 56 syringes Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution
Durham Peptides carries GHK-Cu individually (50mg) as well as the GLOW Blend (70mg) for researchers who want the convenience of a multi-peptide formulation
Rebalance Australian defence resources from the Middle East to the Indo-Pacific
It has not undergone Phase I, II, or III human clinical trials and is not recognized as Generally Recognized as Safe (GRAS)
This helps identify rare side effects, refine usage guidelines, and potentially expand indications
Retatrutides GIPR cAMP EC50 is roughly an order of magnitude lower than tirzepatides, so meaningful GIP signaling happens at a fraction of the dose
